Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation)
Clinical trial NCT01959945 · COMPLETED
Trial details
- NCT number
- NCT01959945
- Sponsor
- Protein Sciences Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-06-01
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.